Pontus Eriksson
31 – 40 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
- Contribution to journal › Article
-
Mark
Promoter-associated proteins of EPAS1 identified by enChIP-MS – A putative role of HDX as a negative regulator
- Contribution to journal › Article
-
Mark
Molecular Characterization of Bladder Cancer Subtypes
- Thesis › Doctoral thesis (compilation)
-
Mark
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- Contribution to journal › Article
-
Mark
Molecular subtype classification of urothelial carcinoma in Lynch syndrome
- Contribution to journal › Article
-
Mark
FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation
- Contribution to journal › Article
- 2017
-
Mark
Molecular classification of urothelial carcinoma : global mRNA classification versus tumour-cell phenotype classification
- Contribution to journal › Article
-
Mark
Cell-Type-Specific Gene Programs of the Normal Human Nephron Define Kidney Cancer Subtypes
- Contribution to journal › Article
-
Mark
Re : Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48-55. Knowing HER2 Status is Not Enough: A Molecular Subtype Approach to Bladder
- Contribution to journal › Debate/Note/Editorial
-
Mark
Novel genetic loci associated with long-term deterioration in blood lipid concentrations and coronary artery disease in European adults
- Contribution to journal › Article
